Realme is all set to expand its popular P-series lineup in India with the Realme P3 Lite 5G, scheduled to launch on September 13, 2025. Ahead of its official debut, the smartphone’s pricing details have surfaced, giving fans a clear idea of what to expect. Designed to balance performance, style, and affordability, the P3 Lite 5G is gearing up to target young buyers looking for value-packed 5G smartphones.
Reports suggest that the Realme P3 Lite 5G will be priced starting at ₹13,999 for the base variant, making it one of the most affordable 5G smartphones in its segment. With Realme’s aggressive pricing strategy, the device is expected to compete directly with rivals like Redmi Note 14 5G, iQOO Z9 Lite, and Samsung Galaxy M15 5G.
While the company has kept full specifications under wraps until launch, leaks and teasers give us a fair picture of what’s coming:
Realme has teased a sleek, lightweight design with gradient finishes aimed at younger users who value aesthetics as much as performance. The slim profile combined with 5G capability makes it a strong contender in the mid-range smartphone space.
The official launch event is set for September 13, where Realme will announce complete details including all variants, availability, and introductory offers. The smartphone is expected to go on sale exclusively via Flipkart and Realme’s official website, followed by availability in offline retail stores.
With its affordable pricing, modern design, and 5G support, the Realme P3 Lite 5G looks like a perfect option for students, professionals, and first-time 5G buyers. If Realme delivers on its promises, the P3 Lite could be another best-seller in India’s competitive mid-range market.
New draft regulations classify breaches of online money gaming protocols as non-bailable violations, extending accountability…
The Finance Ministry said on Thursday that the Department of Revenue (DoR) has been asked…
Chief Economic Advisor V Anantha Nageswaran underscored the critical need for long-term savings to ensure…
The US private sector unexpectedly shed 32,000 jobs in September, according to ADP, defying analysts’…
Pfizer agreed to lower prescription drug costs for Medicaid and invest $70 billion in US…